We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. Cookies are small files of information stored on your device that help us remember your preferences and improve your experience. By clicking ‘Accept All’, you consent to our use of cookies. You are able to reject all non-essential cookies or manage your preferences by . To learn more about our Online Digital and Cookie Notice,
click here.
Cookie Preference Center
Please manage your cookie choices by switching the consent toggles on or off under the Purposes below.
You may change your preference at any time as described in our Cookie Policy
Biological Evaluation of Medical Devices - Part 13: Identification and Quantification of Degradation Products from Polymeric Medical Devices (Adopted ISO 10993-13:1998, first edition, 1998-11-15)
Publication Year 2000
Published by CSA Group
Withdrawn
info Login or Register
A free user account is required to view this document.
This document is purchased as a PDF (Portable Document Format) and accessed via CSA OnDemand™, where you can view, navigate, and print it, or download it for offline use with Adobe Acrobat Viewer. This PDF contains Digital Rights Management protection and is intended for individual use. Please see Terms of Use for CSA’s copyright license and more information.
Pages: 734
PDF
SKU: 2413202
This document is purchased as a PDF (Portable Document Format) and accessed via CSA OnDemand™, where you can view, navigate, and print it, or download it for offline use with Adobe Acrobat Viewer. This PDF contains Digital Rights Management protection and is intended for individual use. Please see Terms of Use for CSA’s copyright license and more information.
This part of ISO 10993 provides guidance on general requirements for the design of tests for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use.
This part of ISO 10993 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test. For materials which are intended to polymerize in situ, the set or cured polymer is used for testing. The data generated are used in the biological evaluation of the polymer.
This part of ISO 10993 considers only those degradation products generated by a chemical alteration of the finished polymeric device. It is not applicable to degradation of the device induced during its intended use by mechanical stress, wear or electromagnetic radiation.
The biological activity of the debris and soluble degradation products is not addressed in this part of ISO 10993, but should be evaluated according to the principles of ISO 10993-1 and ISO 14538.
Because of the wide range of polymeric materials used in medical devices, no specific analytical techniques are identified or given preference. No specific requirements for acceptable levels of degradation products are provided in this part of ISO 10993.
Login or Register
View Access for this document is only available for viewers in Canada